Immunoassay Market Size & Share Report, 2024 – 2032

Immunoassay Market - By Technology (ELISA, CLIA, RIA), Product (Reagent & Kits, Analyzers/Instruments), Specimen (Blood, Saliva, Urine), Application (Oncology, Cardiology), End-use (Hospitals & Clinics, Diagnostic Labs) – Global Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increase in the prevalence of chronic conditions

3.2.1.2&nbsp;&nbsp;&nbsp; Advancements in immunoassay technologies

3.2.1.3&nbsp;&nbsp;&nbsp; Growing demand for point-of-care testing

3.2.1.4&nbsp;&nbsp;&nbsp; Rising awareness and screening programs

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stringent regulatory framework

3.2.2.2&nbsp;&nbsp;&nbsp; Challenges associated with immunoassay

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6.1&nbsp;&nbsp;&nbsp; Supplier power

3.6.2&nbsp;&nbsp;&nbsp; Buyer power

3.6.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.6.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.6.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Reagents &amp; kits

5.2.1&nbsp;&nbsp;&nbsp; ELISA reagents &amp; kits

5.2.2&nbsp;&nbsp;&nbsp; ELISPOT reagents &amp; kits

5.2.3&nbsp;&nbsp;&nbsp; Rapid test reagents &amp; kits

5.2.4&nbsp;&nbsp;&nbsp; Western blot reagents &amp; kits

5.2.5&nbsp;&nbsp;&nbsp; Chemiluminescence immunoassay reagents &amp; kits

5.2.6&nbsp;&nbsp;&nbsp; Immunofluorescence assay reagents &amp; kits

5.2.7&nbsp;&nbsp;&nbsp; Other reagents &amp; kits

5.3&nbsp;&nbsp;&nbsp; Analyzers/Instruments

5.3.1&nbsp;&nbsp;&nbsp; Open ended systems

5.3.2&nbsp;&nbsp;&nbsp; Closed ended systems

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Enzyme-linked immunosorbent assay (ELISA)

6.3&nbsp;&nbsp;&nbsp; Chemiluminescence immunoassay (CLIA)

6.4&nbsp;&nbsp;&nbsp; Radioimmunoassay (RIA)

6.5&nbsp;&nbsp;&nbsp; Immunofluorescence assay (IFA)

6.6&nbsp;&nbsp;&nbsp; Western blotting

6.7&nbsp;&nbsp;&nbsp; ELISpot

6.8&nbsp;&nbsp;&nbsp; Other technologies

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Specimen, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Blood

7.3&nbsp;&nbsp;&nbsp; Saliva

7.4&nbsp;&nbsp;&nbsp; Urine

7.5&nbsp;&nbsp;&nbsp; Other specimens

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Infectious diseases

8.3&nbsp;&nbsp;&nbsp; Oncology

8.4&nbsp;&nbsp;&nbsp; Endocrinology

8.5&nbsp;&nbsp;&nbsp; Cardiology

8.6&nbsp;&nbsp;&nbsp; Autoimmune diseases

8.7&nbsp;&nbsp;&nbsp; Therapeutic drug monitoring

8.8&nbsp;&nbsp;&nbsp; Other applications

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2018-2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

9.3&nbsp;&nbsp;&nbsp; Diagnostic centers

9.4&nbsp;&nbsp;&nbsp; Research and academic laboratories

9.5&nbsp;&nbsp;&nbsp; Homecare settings

9.6&nbsp;&nbsp;&nbsp; Other end-users

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; South Korea

10.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.2&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

11.3&nbsp;&nbsp;&nbsp; Becton Dickinson and Company

11.4&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

11.5&nbsp;&nbsp;&nbsp; Danaher Corporation

11.6&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche AG

11.7&nbsp;&nbsp;&nbsp; Hologic Inc.

11.8&nbsp;&nbsp;&nbsp; Luminex Corporation

11.9&nbsp;&nbsp;&nbsp; PerkinElmer, Inc.

11.10&nbsp;&nbsp;&nbsp; QIAGEN

11.11&nbsp;&nbsp;&nbsp; Sysmex Corporation

11.12&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. 
&nbsp;

Immunoassay Market

Get a free sample of this report